Integra lifesciences holdings corp (IART)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08
OPERATING ACTIVITIES:
Net Income (Loss) Attributable to Parent

50,201

60,801

64,743

74,564

-3,519

34,004

-21,067

41,204

27,989

65,669

50,955

27,727

Adjustments to reconcile net income to net cash provided by operating activities:
Loss from discontinued operations, net of tax

-

-

-

-

-10,370

-2,291

-43,094

-

-

-

-

-

Depreciation and amortization

109,462

110,730

88,945

72,665

58,863

46,434

31,013

52,611

50,172

39,172

39,688

30,717

Non-cash in-process research and development expense

64,916

0

0

-

-

-

-

-

-

-

-

-

Non-cash impairment charges

5,764

4,941

3,290

0

380

790

340

0

0

-

-

-

In-process research and development

-

-

-

-

-

-

-

-

-

-

277

25,240

Deferred income tax benefit/provision

-19,046

-8,184

-67,304

-6,474

-351

-6,849

-1,341

1,537

1,156

4,128

548

-33,542

Share-based compensation

21,255

20,779

21,550

17,310

15,450

14,554

9,842

9,051

26,805

17,209

15,580

32,635

Amortization of debt issuance costs

5,390

6,270

2,722

2,529

2,264

2,571

2,298

2,725

3,387

1,490

2,400

2,431

Non-cash lease expense

5,060

0

0

8,074

7,911

7,104

6,463

8,520

10,591

7,125

9,899

12,471

Realized loss on sale of short-term investments

0

0

-2,287

0

0

-

-

-

-

-

-

-

Loss on disposal of property and equipment

-1,821

-1,385

-6,989

-1,765

-481

-909

-1,965

-1,312

0

0

-

-

Gain on divestiture of business

0

0

2,645

0

0

-

-

-

-

-

-

-

Non-cash valuation allowance

-

-

-

-

37,210

0

0

-

-

-

-

-

Change in fair value of contingent consideration and others

1,119

1,214

-4,710

-13

177

764

0

0

-164

3

-

-

Changes in assets and liabilities:
Gain on bargain purchase

-

-

-

-

1,111

0

0

-

-

-

-

-

Payment Of Accreted Interest Cash Flow

-

-

-

42,786

384

0

0

30,617

0

6,599

-5,391

0

Gain on convertible note repurchases

-

-

-

-

-

-

-

-

-

-

-480

0

Excess tax benefits from stock-based compensation arrangements

-

-

-

-

-

-

270

3,634

848

3,580

20

1,590

Other, net

-

-

-

-

-

-

-

-

-

-

-

18

Changes in assets and liabilities, net of business acquisitions:
Accounts receivable

9,428

17,021

89,698

17,518

16,231

17,145

-1,010

-3,783

1,878

3,783

-9,808

4,710

Inventories

43,308

-8,300

-99

9,576

3,759

24,138

27,364

711

-1,702

7,374

-9,405

-10,823

Prepaid expenses and other current assets

-13,071

-3,933

33,808

-14,912

233

-16,526

-1,996

3,067

395

6,452

-7,029

-3,974

Refundable income taxes

-

-

-

-

-

-

-

-

-

-

-

18,821

Other non-current assets

-13,156

-1,052

914

475

-610

10,914

-1,872

553

-375

179

-411

102

Accounts payable, accrued expenses and other current liabilities

14,666

3,588

95,321

-414

8,208

811

1,334

-21,071

-11,842

6,736

4,550

-17,258

Contract liabilities

-607

1,504

3,874

1,251

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

136

1,118

697

-1,051

104

-457

-289

-372

Other non-current liabilities

-2,059

391

23,803

591

945

-4,357

1,159

-939

-3,154

-7,531

-

-

Net cash provided by operating activities of continuing operations

-

-

-

-

117,063

62,945

53,041

-

-

-

-

-

Net cash used in operating activities of discontinued operations

-

-

-

-

-12,209

20,620

227

-

-

-

-

-

Other liabilities

-

-

-

-

-

-

-

-

-

-

-1,135

2,949

Net cash provided by operating activities

231,433

199,683

114,544

116,405

104,854

83,565

53,268

59,100

104,328

105,571

143,235

72,590

INVESTING ACTIVITIES:
Purchases of property and equipment

69,537

77,741

43,503

47,328

33,413

38,340

42,301

69,031

38,425

37,138

25,238

13,401

Cash used in business acquisitions, net of cash acquired

30,509

-26,704

1,241,946

-225

328,888

320,921

2,980

7,278

151,951

5,178

60,783

86,874

Acquired in-process research and development

64,995

0

0

-

-

-

-

-

-

-

-

-

Change in restricted cash

-

-

-

-4,165

4,087

0

0

64,940

0

0

-

-

Proceeds from sale of short-term investments

0

0

-16,951

0

0

-

-

-

-

-

-

-

Proceeds from note receivable

752

910

483

0

0

-

-

-

-

-

-

-

Proceeds from sale of property and equipment

37

422

293

316

1,438

0

535

0

0

-

-

-

Proceeds from divestiture of business

0

0

46,387

0

0

-

-

-

-

-

-

-

Net proceeds on swaps designated as net investment hedges

1,584

0

0

-

-

-

-

-

-

-

-

-

Other changes in intangible assets

-

-

-

-

-

475

0

0

-

-

-

-

Purchases of short-term investments

-

-

-

-

-

-

-

67,907

0

0

-

-

Net cash used in investing activities of continuing operations

-

-

-

-

-364,950

-359,736

-44,746

-

-

-

-

-

Net cash used in investing activities of discontinued operations

-

-

-

-

-7,060

-3,581

-5,550

-

-

-

-

-

Payments to Acquire Intangible Assets

-

-

-

-

-

-

-

-

-

-

2,331

0

Net cash used in investing activities

-162,668

-49,705

-1,221,335

-42,622

-372,010

-363,317

-50,296

-79,276

-190,376

-42,316

-88,352

-100,275

FINANCING ACTIVITIES:
Proceeds from borrowings of long-term indebtedness

236,900

171,200

1,307,000

680,000

545,000

425,000

30,000

155,000

145,000

105,000

-

260,000

Payments on debt

246,100

660,000

117,000

511,250

465,625

195,000

165,000

12,812

213,437

16,875

100,000

0

Purchase of option hedge on convertible notes

-

-

-

-

-

-

-

-

42,895

0

-

-

Proceeds from the issuance of common stock, net of issuance costs

0

349,590

0

0

219,669

0

152,458

0

0

-

-

-

Distribution to SeaSpine

-

-

-

-

-47,013

0

0

-

-

-

-

-

Payment of liability component of convertible notes

-

-

-

184,313

2,519

0

0

134,383

0

71,351

78,005

119,558

Payment of capital lease obligation

-

-

-

653

709

605

0

0

-

-

-

-

Proceeds from Convertible Debt

-

-

-

-

-

-

-

-

186,830

0

-

-

Net cash paid for contingent consideration

0

38,196

4,661

0

0

-

-

-

-

-

-

-

Proceeds from equity component of convertible notes

-

-

-

-

-

-

-

-

43,170

0

-

-

Proceeds from sale of stock purchase warrants

-

-

-

-

-

-

-

-

28,451

0

-

-

Payment of debt issuance costs

0

5,037

19,043

4,530

1,426

3,210

1,053

385

8,064

6,796

-

0

Purchases of treasury stock

-

-

-

-

-

-

-

-

83,463

31,278

-

0

Proceeds from exercised stock options

6,948

9,392

9,774

10,481

7,345

15,215

2,344

696

3,697

16,146

6,643

11,504

Cash taxes paid in net equity settlement

6,514

7,821

7,123

-4,851

-6,580

-2,718

270

3,634

848

3,580

20

1,590

Net cash provided by financing activities

-8,766

-180,872

1,168,947

-15,116

248,142

238,682

19,019

11,750

60,137

-1,574

-171,342

153,536

Effect of exchange rate changes on cash and cash equivalents

74

-5,203

10,724

-4,744

-4,848

-7,550

1,685

4,556

-2,044

-4,809

4,804

356

Net increase in cash and cash equivalents

60,073

-36,097

72,880

53,923

-23,862

-48,620

23,676

-3,870

-27,955

56,872

-111,655

126,207